Lunit Past Earnings Performance
Past criteria checks 0/6
Lunit has been growing earnings at an average annual rate of 16.2%, while the Healthcare Services industry saw earnings growing at 15.2% annually. Revenues have been declining at an average rate of 11.9% per year.
Key information
16.2%
Earnings growth rate
57.9%
EPS growth rate
| Healthcare Services Industry Growth | 16.7% |
| Revenue growth rate | -11.9% |
| Return on equity | -20.4% |
| Net Margin | -239.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Lunit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 19,249 | -46,024 | 48,930 | 18,649 |
| 31 Dec 23 | 25,080 | -36,798 | 46,526 | 16,639 |
| 30 Sep 23 | 23,626 | -39,226 | 42,732 | 15,163 |
| 30 Jun 23 | 24,805 | -44,762 | 41,583 | 15,275 |
| 31 Mar 23 | 21,861 | -19,443 | 42,091 | 15,617 |
| 31 Dec 22 | 13,866 | -39,118 | 42,792 | 18,364 |
| 30 Sep 22 | 14,017 | -42,801 | 41,620 | 20,592 |
| 30 Jun 22 | 10,715 | -52,413 | 38,900 | 20,868 |
| 31 Mar 22 | 9,076 | -85,907 | 33,791 | 23,336 |
| 31 Dec 21 | 6,639 | -73,676 | 27,879 | 22,298 |
| 31 Dec 20 | 1,430 | -83,739 | 11,928 | 9,058 |
| 31 Dec 19 | 198 | -46,972 | 6,860 | 4,545 |
| 31 Dec 18 | 20 | -8,210 | 3,562 | 2,966 |
Quality Earnings: A328130 is currently unprofitable.
Growing Profit Margin: A328130 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A328130 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.2% per year.
Accelerating Growth: Unable to compare A328130's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A328130 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.1%).
Return on Equity
High ROE: A328130 has a negative Return on Equity (-20.43%), as it is currently unprofitable.